Endeshaw Tekola, Kebede Amha, Verweij Jaco J, Zewide Ayele, Tsige Kebede, Abraham Yodit, Wolday Dawit, Woldemichael Tilahun, Messele Tsehaynesh, Polderman Anton M, Petros Beyene
Ethiopian Health and Nutrition Research Institute, Addis Ababa, Ethiopia.
Jpn J Infect Dis. 2006 Oct;59(5):306-10.
Intestinal microsporidiosis is most commonly associated with persistent diarrhea in advanced AIDS cases. To determine the prevalence and clinical manifestations of this infection in HIV/AIDS patients, a single fresh stool sample and blood were collected from 243 (214 HIV-positive and 29 HIV-negative) diarrheal patients. The presence of intestinal microsporidiosis in the stool was determined by Uvitex-2B staining and a PCR-based detection method. HIV screening was done by using ELISA, and reactive samples were confirmed by Western blotting. The CD4+ cell count was analyzed using FACScan. Out of 243 diarrheal patients, 39 (16.0%) cases were positive for intestinal microsporidial infection by either of the methods used. Of the 39, only 18 cases positive by microscopy were also positive by PCR. Based on PCR and microscopic analyses the microsporidial parasites were identified as Enterocytozoon bieneusi (30), Ecephalitozoon intestinalis (6), and double infections (3). All microsporidia-positive cases were HIV-positive, and 92.3% had diarrhea for over 4 weeks. The diarrhea was watery in 79.5% of the patients. Weight loss >10% was recorded in 37 (94.9%) cases. The CD4+ cell count was <100 cells/mm(3) in 84.4% of subjects, and 59.4% of the patients had a CD4+ cell count of < or =50 cells/mm(3), with a mean of 22.8 cells/mm(3). This study revealed that intestinal microsporidiosis is a common cause of chronic diarrhea and severe weight loss in advanced AIDS patients in Ethiopia. This condition is attributable mainly to E. bieneusi. Thus, early diagnosis of intestinal microsporidiosis in HIV/AIDS patients would certainly be helpful in the understanding and management of diarrheal illness.
肠道微孢子虫病最常与晚期艾滋病患者的持续性腹泻相关。为确定这种感染在艾滋病毒/艾滋病患者中的患病率和临床表现,从243例腹泻患者(214例艾滋病毒阳性和29例艾滋病毒阴性)中采集了一份新鲜粪便样本和血液。通过乌洛托品-2B染色和基于聚合酶链反应(PCR)的检测方法来确定粪便中是否存在肠道微孢子虫病。采用酶联免疫吸附测定法(ELISA)进行艾滋病毒筛查,反应性样本通过蛋白质印迹法进行确认。使用流式细胞仪分析CD4 +细胞计数。在243例腹泻患者中,采用的任何一种方法检测出39例(16.0%)肠道微孢子虫感染呈阳性。在这39例中,仅18例显微镜检查呈阳性的病例经PCR检测也呈阳性。基于PCR和显微镜分析,微孢子虫寄生虫被鉴定为比氏肠微孢子虫(30例)、肠脑炎微孢子虫(6例)和双重感染(3例)。所有微孢子虫阳性病例均为艾滋病毒阳性,92.3%的患者腹泻超过4周。79.5%的患者腹泻呈水样。37例(94.9%)病例记录体重减轻超过10%。84.4%的受试者CD4 +细胞计数<100个细胞/mm³,59.4%的患者CD4 +细胞计数≤50个细胞/mm³,平均为22.8个细胞/mm³。这项研究表明,肠道微孢子虫病是埃塞俄比亚晚期艾滋病患者慢性腹泻和严重体重减轻的常见原因。这种情况主要归因于比氏肠微孢子虫。因此,艾滋病毒/艾滋病患者肠道微孢子虫病的早期诊断肯定有助于理解和管理腹泻疾病。